bromodeoxyuridine has been researched along with Cancer of Skin in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.77) | 18.7374 |
| 1990's | 17 (32.69) | 18.2507 |
| 2000's | 22 (42.31) | 29.6817 |
| 2010's | 8 (15.38) | 24.3611 |
| 2020's | 2 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Botvinnik, A; Britan-Rosich, E; Climent, N; Kotler, M; Manevitch, Z; Moshel, O; Oliva, H; Olshevsky, U; Sharma, G; Shivam, P; Smith, Y | 1 |
| Hamana, H; Hayakawa, Y; Kishi, H; Lyu, F; Mojic, M; Ohshima, C; Shitaoka, K; Tahara, H; Ucche, S | 1 |
| Singh, S | 1 |
| Guo, S; He, X; Lan, H; Lan, T; Li, J; Li, W; Qi, C; Wang, L; Wei, P; Yang, Y; Ye, J; Zhang, Q | 1 |
| Costa, VM; Diniz, C; Fresco, P; Soares, AS | 1 |
| Bai, X; Chuong, CM; Lai, X; Lei, M; Lian, X; Liao, X; Qiu, W; Yang, L; Yang, T; Zhong, JL | 1 |
| Bedford, MT; Benavides, F; Conti, CJ; Del Río, M; Dent, SYR; DiGiovanni, J; Espejo, A; Giulivi, C; Guénet, JL; Iritani, BM; Jaubert, J; Kusewitt, DF; Martinez-Santamaria, L; Mecklenburg, L; Napoli, E; Perez, CJ; Song, G; Wood, RD | 1 |
| Chen, GS; Hou, PS; Huang, SM; Lai, HC; Lan, CE; Peng, YT; Wu, CH; Wu, CS; Yang, HJ | 1 |
| Chen, Y; Jiang, Y; Liu, W; Ma, H; Wang, Z; Xie, X; Zhang, Y | 1 |
| Rieber, M; Rieber, MS | 1 |
| Achouri, Y; Blanpain, C; Lapouge, G; Michaux, C; Sotiropoulou, PA; Vokaer, B; Youssef, KK | 1 |
| Kinashi, Y; Kondo, N; Liu, Y; Maruhashi, A; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
| Aberger, F; Eichberger, T; Frischauf, AM; Hintner, H; Ikram, MS; Kasper, M; Koller, J; Neill, GW; Quinn, AG; Regl, G | 1 |
| Conney, AH; Huang, MT; Liao, J; Lou, YR; Lu, YP; Peng, QY; Xie, JG; Yang, CS | 1 |
| Iidaka, T; Masegi, T; Noda, A; Sakai, H; Shirai, N; Yanai, T | 1 |
| Sundberg, JP; Welsh, J; Zinser, GM | 1 |
| Blázquez, C; Casanova, ML; Fernández-Aceñero, MJ; Guzmán, M; Huffman, JW; Jorcano, JL; Martínez-Palacio, J; Villanueva, C | 1 |
| Laing, JH; Martindale, CA; Wilson, GD | 1 |
| Agarwal, C; Agarwal, R; Dhanalakshmi, S; Mallikarjuna, G; Singh, RP | 1 |
| Sakaguchi, K; Takata, K; Yamaguchi, M; Yoshida, H | 1 |
| Blanche, M; Dunois-Lardé, C; Gasc, JM; Jorcano, J; Levrel, O; Logié, A; Radvanyi, F; Ribeiro, A; Rosty, C; Sastre-Garau, X; Thiery, JP; Werner, S | 1 |
| Baker, JH; Huxham, LA; Kyle, AH; McNicol, KL; Minchinton, AI | 1 |
| Chiu, LC; Ooi, VE; Tong, KF | 1 |
| Fischer, SM; He, G; Hwang, DH; Sung, YM | 1 |
| Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y | 1 |
| de Villiers, EM; Gruber, AD; Kopp-Schneider, A; Michel, A; Zentgraf, H | 1 |
| de Gruijl, FR; Mitchell, DL; Mulder, AA; Mullenders, LH; Nijhof, JG; van Pelt, C | 1 |
| Andersson, U; Bamberg, K; Berg, AL; Blomgren, B; Camejo, G; Dahl, B; Dillner, B; Elebring, M; Evans, J; Hellmold, H; Holland, T; Lundholm, E; Roberts, R; Sjögren, N; Skånberg, I; Tugwood, J; Westerberg, R; Zhang, H | 1 |
| Blessing, M; Hogan, BL; King, LE; Nanney, LB | 1 |
| Clifford, A; Gilmour, S; Morgan, D; Soler, AP; Yuspa, SH | 1 |
| Healy, E; Morley, A; Rees, JL; Smith, MD; Thompson, V | 1 |
| Inokuchi, T; Sano, K; Uehara, M | 1 |
| Anisimov, VN; Sheiko, EV | 1 |
| Hagiwara, A; Kawabe, M; Nakamura, T; Sano, M; Shibata, MA; Sugimoto, H; Takesada, Y; Tamano, S; Tanaka, H | 1 |
| Huang, MT; Inouye, M; Lou, YR; Lu, YP; Mirochnitchenko, OI; Newmark, HL; Yen, P | 1 |
| Berton, TR; Fischer, SM; Locniskar, MF; Mitchell, DL | 1 |
| Foley, JF; Kim, TW; Maronpot, RR; Porter, KL; Smart, RC | 1 |
| Conney, AH; Huang, MT; Lou, YR; Lu, YP; Xie, JG; Yen, P | 1 |
| Brinkley, BR; Greenhalgh, DA; He, D; Jiang, A; Medina, D; Roop, DR; Wang, XJ; Zhong, L | 1 |
| Olive, PL; Vanderbyl, S; Vikse, CM | 1 |
| Kanzaki, T; Nakano, R; Ohtake, N | 1 |
| Johnson, DG; Russell, J; Wang, D; Xu, H | 1 |
| Conti, CJ; Johnson, DG; Rounbehler, RJ; Schneider-Broussard, R | 1 |
| Beason, CW; Dick, EJ; DiGiovanni, J; Dusch, SJ; Jauchem, JR; Mahajan, K; Mason, PA; Merritt, JH; Murphy, MR; Ryan, KL; Shields, BA; Walters, TJ | 1 |
| Johnson, PF; Smart, RC; Sterneck, E; Yoon, K; Zhu, S | 1 |
| Laing, JH; Rew, DA; Wilson, GD | 1 |
| Amagai, M; Hayakawa, K; Kitagawa, K; Miyakawa, S; Shimizu, N; Ueda, M | 1 |
| Bando, M; Morimoto, Y; Saga, K; Takahashi, M | 1 |
| Egawa, K; Ono, T; Yoshimura, K | 1 |
| Oku, T; Takigawa, M; Yamada, M | 1 |
| Fürstenberger, G; Fusenig, NE; Marks, F; Petrusevska, RT | 1 |
| Cleaver, JE | 1 |
2 trial(s) available for bromodeoxyuridine and Cancer of Skin
| Article | Year |
|---|---|
Proliferation rates in human malignant melanoma: relationship to clinicopathological features and outcome.
Topics: Aged; Bromodeoxyuridine; Cell Division; Disease-Free Survival; DNA, Neoplasm; Female; Humans; Male; Melanoma; Middle Aged; Mitosis; Prognosis; S Phase; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Differentiation of malignant lymphoma and non-lymphoma by an occlusive dressing method employing bromodeoxyuridine.
Topics: Biopsy; Bromodeoxyuridine; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Mycosis Fungoides; Occlusive Dressings; Sensitivity and Specificity; Skin Diseases; Skin Neoplasms; Specimen Handling | 1999 |
50 other study(ies) available for bromodeoxyuridine and Cancer of Skin
| Article | Year |
|---|---|
APOBEC3G rescues cells from the deleterious effects of DNA damage.
Topics: APOBEC-3G Deaminase; Bromodeoxyuridine; DNA Damage; DNA Repair; Humans; Lymphoma, T-Cell; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays | 2021 |
NKG2D defines tumor-reacting effector CD8
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Bromodeoxyuridine; CD8-Positive T-Lymphocytes; Interferon-gamma; Luciferases; Luminescent Measurements; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; NK Cell Lectin-Like Receptor Subfamily K; Ovalbumin; Skin Neoplasms; Tumor Microenvironment; Vaccination | 2021 |
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Celecoxib; Cell Line, Tumor; Cell Survival; Disease Progression; Doxorubicin; Humans; Liposomes; Particle Size; Skin Neoplasms; Static Electricity | 2018 |
Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Basement Membrane; Blood Vessels; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Collagen Type IV; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Neoplasm Invasiveness; Nerve Tissue Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Burden | 2014 |
Inosine strongly enhances proliferation of human C32 melanoma cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K pathways.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Humans; Inosine; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Signal Transduction; Skin Neoplasms; Tetrazolium Salts; Thiazoles | 2015 |
Prolonged overexpression of Wnt10b induces epidermal keratinocyte transformation through activating EGF pathway.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Proliferation; Cell Transformation, Neoplastic; Epidermal Cells; Epidermal Growth Factor; Epidermis; Humans; Intercellular Signaling Peptides and Proteins; Keratinocytes; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins; Signal Transduction; Skin Neoplasms; Tumor Stem Cell Assay; Wnt Proteins | 2015 |
Increased Susceptibility to Skin Carcinogenesis Associated with a Spontaneous Mouse Mutation in the Palmitoyl Transferase Zdhhc13 Gene.
Topics: Acyltransferases; Animals; Bromodeoxyuridine; Codon, Terminator; Epidermal Cells; Genetic Predisposition to Disease; Keratinocytes; Leukocyte Elastase; Mice; Mutation; Neutrophil Infiltration; NF-kappa B; NIH 3T3 Cells; Phenotype; Skin Neoplasms | 2015 |
Irradiance-dependent UVB Photocarcinogenesis.
Topics: Adult; Animals; Bromodeoxyuridine; Butadienes; Carcinogenesis; Cell Count; Cell Survival; Cells, Cultured; Dermatitis, Contact; DNA Damage; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Humans; Immunosuppression Therapy; Keratinocytes; Mice, Hairless; Mitosis; Mutation; Nitriles; Protein Kinase Inhibitors; Pyrimidine Dimers; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2016 |
Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse.
Topics: Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Carcinogens; Cell Division; Intracellular Signaling Peptides and Proteins; Keratinocytes; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Skin Neoplasms; Tumor Suppressor Proteins | 2008 |
Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy.
Topics: Apoptosis; Autophagy; Bromodeoxyuridine; Cell Line, Tumor; Cyclin A; Cyclin-Dependent Kinase 2; DNA Damage; Humans; Melanoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Skin Neoplasms; Ultraviolet Rays; Vacuoles | 2008 |
Identifying the cellular origin of squamous skin tumors.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Lineage; DNA Primers; Epidermal Cells; Flow Cytometry; Hair Follicle; Integrases; Mice; Mice, Transgenic; Proto-Oncogene Proteins p21(ras); Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Stem Cells | 2011 |
Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Topics: Animals; Antineoplastic Agents; Borohydrides; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Hypoxia; Female; Hyperthermia, Induced; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Niacinamide; Radiation-Sensitizing Agents; Skin Neoplasms; Sulfhydryl Compounds; Vitamin B Complex | 2012 |
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
Topics: Alkaline Phosphatase; Blotting, Western; Bromodeoxyuridine; Carcinoma, Basal Cell; DNA Primers; DNA, Neoplasm; Enzyme Activation; Feedback, Physiological; Flow Cytometry; Green Fluorescent Proteins; Hedgehog Proteins; Humans; Keratinocytes; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Membrane Proteins; Nuclear Proteins; Oncogene Proteins; Patched Receptors; Polymerase Chain Reaction; Receptors, Cell Surface; Retroviridae; RNA; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Zinc Finger Protein GLI1; Zinc Finger Protein Gli2; Zinc Fingers | 2002 |
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice.
Topics: Administration, Topical; Animals; Apoptosis; Bromodeoxyuridine; Caffeine; Caspase 3; Caspases; Catechin; Female; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Skin Neoplasms; Tea; Ultraviolet Rays | 2002 |
Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cell Nucleus; Dog Diseases; Dogs; Immunoenzyme Techniques; Ki-67 Antigen; Mastocytoma; Mitotic Index; Neoplasm Staging; Skin Neoplasms | 2002 |
Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alleles; Animals; Bromodeoxyuridine; Carcinogens; Cell Division; Homozygote; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; Receptors, Calcitriol; Sex Factors; Skin; Skin Neoplasms; Time Factors | 2002 |
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Topics: Angiogenesis Inducing Agents; Angiopoietin-2; Animals; Antineoplastic Agents; Apoptosis; Benzoxazines; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cannabinoids; Cell Line, Transformed; Endothelial Growth Factors; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Lymphokines; Mice; Morpholines; Naphthalenes; Neovascularization, Pathologic; Receptors, Cannabinoid; Receptors, Drug; Skin Neoplasms; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
Topics: Administration, Oral; Administration, Topical; Animals; Apoptosis; Bromodeoxyuridine; Caspase 3; Caspases; Cell Cycle Proteins; Cell Division; Enzyme Activation; Female; MAP Kinase Signaling System; Mice; Mice, Hairless; Mitogen-Activated Protein Kinases; Neoplasms, Radiation-Induced; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Silybin; Silymarin; Skin; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays; Up-Regulation | 2004 |
Drosophila damaged DNA-binding protein 1 is an essential factor for development.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Bromodeoxyuridine; DNA Repair; DNA-Binding Proteins; Drosophila melanogaster; Drosophila Proteins; Endodeoxyribonucleases; Eye; Female; Gene Expression Regulation, Developmental; Gene Silencing; Genes, Lethal; Male; Phenotype; Recombinant Fusion Proteins; RNA Interference; RNA, Double-Stranded; Skin Neoplasms | 2004 |
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Topics: Animals; Bromodeoxyuridine; DNA Mutational Analysis; Gene Expression; Humans; Immunohistochemistry; Keratosis, Seborrheic; Mice; Mice, Transgenic; Point Mutation; Polymorphism, Single-Stranded Conformational; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skin Neoplasms; Transgenes | 2005 |
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Blood Vessels; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Female; HCT116 Cells; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred NOD; Mice, SCID; Necrosis; Platelet Endothelial Cell Adhesion Molecule-1; Regional Blood Flow; Skin Neoplasms; Tirapazamine; Transplantation, Heterologous; Triazines | 2006 |
Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells.
Topics: Antineoplastic Agents; Aspirin; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Docosahexaenoic Acids; Drug Synergism; Humans; Indomethacin; Melanoma, Experimental; Piroxicam; Skin Neoplasms; Tetrazolium Salts; Thiazoles | 2005 |
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cattle; Cell Culture Techniques; Cell Proliferation; Female; Humans; Hyperplasia; Inflammation; Keratinocytes; Keratins; Mice; Mice, Transgenic; Neovascularization, Pathologic; Polymerase Chain Reaction; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Skin Neoplasms; Tetradecanoylphorbol Acetate; Up-Regulation | 2006 |
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Fluorescent Antibody Technique; Gamma Rays; Hyperthermia, Induced; Infusions, Parenteral; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neutrons; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Neoplasms; Tirapazamine; Treatment Outcome; Triazines | 2006 |
E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.
Topics: Alphapapillomavirus; Animals; Betapapillomavirus; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Epidermis; Female; Histocytochemistry; Immunohistochemistry; Keratin-6; Male; Membrane Proteins; Mice; Mice, Transgenic; Oncogene Proteins, Viral; Papilloma; Papillomavirus Infections; Phosphoproteins; Protein Precursors; Skin; Skin Neoplasms; Trans-Activators; Tumor Suppressor Protein p53 | 2006 |
Epidermal stem and progenitor cells in murine epidermis accumulate UV damage despite NER proficiency.
Topics: Animals; Antigens, Surface; Bromodeoxyuridine; DNA Damage; DNA Repair; DNA-Binding Proteins; Epidermal Cells; Fibroblasts; Humans; Membrane Glycoproteins; Mice; Mice, Hairless; Mice, Knockout; Mice, Transgenic; Photobiology; Pyrimidine Dimers; Radiation Tolerance; Skin Neoplasms; Stem Cells; Tumor Suppressor Protein p53; Ultraviolet Rays | 2007 |
Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.
Topics: Alkanesulfonates; Animals; Antimetabolites; Bromodeoxyuridine; Cholesterol; DNA; DNA Replication; Female; Fibrosarcoma; Hypoglycemic Agents; Immunohistochemistry; Male; Mesoderm; Microdissection; Organ Size; Phenylpropionates; PPAR alpha; PPAR gamma; Protein Binding; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Skin Neoplasms; Triglycerides | 2007 |
Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene.
Topics: Animals; Bone Morphogenetic Proteins; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Epidermis; Methylnitronitrosoguanidine; Mice; Mice, Transgenic; Papilloma; Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta | 1995 |
Role of ornithine decarboxylase in epidermal tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Line; Cells, Cultured; Fibroblasts; Genetic Vectors; Keratinocytes; Mice; Mice, Inbred BALB C; Ornithine Decarboxylase; Papilloma; Polyamines; Recombinant Proteins; Retroviridae; Skin Neoplasms; Skin Transplantation; Tetradecanoylphorbol Acetate; Transfection | 1995 |
Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki67 antigen and BrdU incorporation.
Topics: Bowen's Disease; Bromodeoxyuridine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Histones; Humans; In Situ Hybridization; In Vitro Techniques; Keratosis; Ki-1 Antigen; Ki-67 Antigen; Mitotic Index; Neoplasm Proteins; Nuclear Proteins; Psoriasis; RNA, Messenger; Skin; Skin Neoplasms | 1995 |
Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse.
Topics: Aluminum Silicates; Animals; Antimetabolites; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Hematoporphyrin Photoradiation; Hematoporphyrins; Hyperthermia, Induced; Laser Therapy; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Necrosis; Neodymium; Photosensitizing Agents; Skin Neoplasms; Yttrium | 1996 |
[Skin carcinogenesis induced be neonatal administration of 5-bromo-2'-deoxyuridine and subsequent treatment with 12-O-tetradecanoylphorbol-13-acetate in mice].
Topics: Animals; Bromodeoxyuridine; Carcinogens; Female; Male; Mice; Mice, Hairless; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1996 |
Lack of tumor promoting effects of KCB-1, a recombinant human basic fibroblast growth factor, on two-stage skin carcinogenesis in female CD-1 (ICR) mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Body Weight; Bromodeoxyuridine; Cell Nucleus; Cocarcinogenesis; Disease Models, Animal; Female; Fibroblast Growth Factor 2; Fibroblast Growth Factors; Hematopoiesis; Immunohistochemistry; Incidence; Mice; Mice, Inbred ICR; Papilloma; Recombinant Proteins; Skin Neoplasms | 1996 |
Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; DNA; Female; Glutathione Peroxidase; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Papilloma; Skin; Skin Neoplasms; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53 | 1997 |
Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis.
Topics: Animals; Bromodeoxyuridine; Cell Division; DNA; DNA Damage; Female; Gene Expression; Genes, p53; Genetic Predisposition to Disease; Hyperplasia; Mice; Mice, Hairless; Mice, Inbred SENCAR; Neoplasms, Radiation-Induced; Ornithine Decarboxylase; Pyrimidine Dimers; Skin; Skin Neoplasms; Ultraviolet Rays | 1997 |
Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Cocarcinogenesis; Female; Genes, ras; Genotype; Immunohistochemistry; Keratinocytes; Mice; Mice, Inbred BALB C; Mirex; Mutation; Nitrosourea Compounds; Papilloma; S Phase; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1997 |
Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; DNA; Female; Keratoacanthoma; Mice; Mitosis; Papilloma; Skin Neoplasms; Tea; Ultraviolet Rays | 1997 |
Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; Centrosome; Disease Susceptibility; Epidermis; Female; Gene Amplification; Humans; Keratins; Male; Mice; Mice, Transgenic; Mutagenesis, Site-Directed; Papilloma; Promoter Regions, Genetic; Proto-Oncogene Proteins p21(ras); ras Proteins; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transgenes; Tumor Suppressor Protein p53 | 1998 |
Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation.
Topics: Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Division; Cell Survival; DNA Damage; DNA, Neoplasm; Flow Cytometry; G1 Phase; Humans; Mice; Mice, SCID; Microscopy, Electron; Necrosis; Neoplasm Transplantation; Radiotherapy Dosage; Skin Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
Topics: Animals; Apoptosis; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Nucleus; Epidermal Cells; Epidermis; Immunohistochemistry; In Situ Nick-End Labeling; Keratins; Mice; Mice, Transgenic; Promoter Regions, Genetic; Protein Structure, Tertiary; Skin; Skin Neoplasms; Time Factors; Transcription Factor DP1; Transcription Factors; Transcriptional Activation; Transgenes | 2001 |
Myc lacks E2F1's ability to suppress skin carcinogenesis.
Topics: Age Factors; Animals; Apoptosis; Blotting, Northern; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Epidermis; Exons; Genes, p53; In Situ Nick-End Labeling; Keratin-15; Keratin-5; Keratins; Mice; Mice, Transgenic; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Skin Neoplasms; Time Factors; Transcription Factors; Transgenes | 2001 |
Lack of effect of 94 GHz radio frequency radiation exposure in an animal model of skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Carcinogens; Cocarcinogenesis; Dose-Response Relationship, Drug; Drug Administration Schedule; Electromagnetic Fields; Female; Incidence; Mice; Mice, Inbred SENCAR; Neoplasms, Radiation-Induced; Ornithine Decarboxylase; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2001 |
CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
Topics: 3T3 Cells; 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Carcinogens; CCAAT-Enhancer-Binding Protein-beta; Cell Division; Cell Survival; Genes, Reporter; Keratinocytes; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutagens; Mutation; Oncogene Protein p21(ras); Phosphorylation; Signal Transduction; Skin Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Transcriptional Activation | 2002 |
Cell kinetics of human solid tumours.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Colorectal Neoplasms; Flow Cytometry; Humans; Melanoma; Prognosis; Prospective Studies; Skin Neoplasms | 1992 |
Trichilemmal tumor arising in a seborrheic keratosis: analysis of cell kinetics by BrdU staining.
Topics: Aged; Bromodeoxyuridine; Cell Cycle; Dermatitis, Seborrheic; DNA Replication; Humans; Immunohistochemistry; Keratosis; Male; Skin; Skin Neoplasms; Staining and Labeling | 1991 |
In-vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrhoeic keratosis, Bowen's disease and basal cell carcinoma.
Topics: Bowen's Disease; Bromodeoxyuridine; Carcinoma, Basal Cell; Dermatitis, Seborrheic; DNA; Humans; Immunohistochemistry; Keratinocytes; Keratosis; Psoriasis; Skin; Skin Diseases; Skin Neoplasms | 1991 |
[Proliferating patterns of basal cell carcinoma--immunohistological study by means of anti-BrdU monoclonal antibody].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Basal Cell; Cell Division; Female; Humans; Immunohistochemistry; Male; Middle Aged; Skin Neoplasms | 1990 |
Cell proliferation kinetics of cultured human keratinocytes and fibroblasts measured using a monoclonal antibody.
Topics: Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; Carcinoma, Basal Cell; Cell Division; Culture Techniques; Epidermis; Fibroblasts; Humans; Immunoenzyme Techniques; Keratins; Kinetics; Skin Neoplasms | 1987 |
Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Aneuploidy; Antipain; Bromodeoxyuridine; Carcinogens; Cells, Cultured; Chromosome Aberrations; Chromosome Mapping; Cocarcinogenesis; DNA; Epidermal Cells; Epidermis; Ornithine Decarboxylase; Phorbol Esters; Skin Neoplasms; Structure-Activity Relationship | 1988 |
Defective repair replication of DNA in xeroderma pigmentosum.
Topics: Autoradiography; Bromodeoxyuridine; Centrifugation, Density Gradient; DNA Replication; Fibroblasts; Genes, Recessive; Humans; Mutation; Neoplasm Metastasis; Radiation Injuries; Skin Neoplasms; Sunlight; Thymidine; Tritium; Ultraviolet Rays; Xeroderma Pigmentosum | 1968 |